OmniAb, Inc. OABI

Updated: 11 Aug 2026

NASDAQ | Biotech | Antibody discovery platform

No signal published yet

We already track OmniAb and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow OmniAb free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Antibody discovery platform
We're already tracking OmniAb, Inc. — here are the latest events we've registered

Recent News

  • On August 6, 2026, OmniAb reported its second-quarter 2026 financial results, showing total revenue of $13.4 million compared to $3.9 million in the prior-year period. The growth was primarily driven by clinical milestone payments from partner programs advancing through development. Following the quarter, the company raised its full-year 2026 revenue guidance to a range of $32 million to $36 million.

What Firelda Watch includes for OmniAb, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of OmniAb, Inc. will be delivered in the same format.

Want to follow OmniAb, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow OmniAb free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

OmniAb, Inc. OABI
OmniAb — follow and we'll monitor it
Follow OmniAb free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.